| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Mar 12, 2026 |
LifeMD Inc
LFMD
|
BUY |
$10.00
Est. +158%
|
$3.88 | $5.38 |
Pending
|
$4.87
+25.5%
|
| Mar 03, 2026 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$25.00
Est. +58%
|
$15.87 | $23.85 |
Pending
|
$19.28
+21.5%
|
| Mar 02, 2026 |
Butterfly Network Inc - Ordinary Shares - Class A
BFLY
|
BUY |
$5.50
Est. +46%
|
$3.77 | $9.69 |
Target Met
|
$7.68
+103.7%
|
| Mar 02, 2026 |
Biomarin Pharmaceutical Inc. - Registered Shares
BMRN
|
BUY |
$105.00
Est. +74%
|
$60.47 | $61.97 |
Pending
|
$58.99
-2.4%
|
| Feb 10, 2026 |
Lilly(Eli) & Co
LLY
|
BUY |
$1,200.00
Est. +17%
|
$1,025.00 | $1,238.00 |
Target Met
|
$1,210.50
+18.1%
|
| Jan 29, 2026 |
Abbott Laboratories
ABT
|
BUY |
$120.00
Est. +13%
|
$106.09 | $116.82 |
Precision Hit (±3%)
|
$95.39
-10.1%
|
| Jan 27, 2026 |
Johnson & Johnson
JNJ
|
SELL |
$220.00
Est. +2%
|
$225.16 | $220.37 (Low) |
Bullseye Hit (±1%)
|
$263.04
-16.8%
|
| Dec 31, 2025 |
Butterfly Network Inc - Ordinary Shares - Class A
BFLY
|
BUY |
$5.00
Est. +31%
|
$3.82 | $9.69 |
Target Met
|
$7.68
+101.0%
|
| Nov 24, 2025 |
LifeMD Inc
LFMD
|
BUY |
$8.00
Est. +102%
|
$3.97 | $5.38 |
Pending
|
$4.87
+22.7%
|
| Nov 10, 2025 |
Lilly(Eli) & Co
LLY
|
SELL |
$950.00
Est. +2%
|
$969.84 | $850.51 (Low) |
Target Met
|
$1,210.50
-24.8%
|
| Oct 22, 2025 |
Johnson & Johnson
JNJ
|
SELL |
$190.00
Est. +2%
|
$193.18 | $184.66 (Low) |
Precision Hit (±3%)
|
$263.04
-36.2%
|